Related Experiment Videos
L-dopa-responsive infantile hypokinetic rigid parkinsonism due to tyrosine hydroxylase deficiency
J F de Rijk-Van Andel1, F J Gabreëls, B Geurtz
1Department of Neurology, Ignatius Hospital Breda, Nijmegen, The Netherlands.
Insights
Tyrosine hydroxylase deficiency causes early-infancy parkinsonism in Dutch patients. Low-dose L-dopa/carbidopa treatment improved motor function but did not fully normalize it.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Tyrosine hydroxylase (TH) is the rate-limiting enzyme in catecholamine synthesis.
- Deficiency in TH can lead to neurological disorders.
- Early-onset parkinsonism is a rare condition with diverse etiologies.
Observation:
- Four unrelated Dutch patients presented with a hypokinetic-rigid parkinsonian syndrome.
- Symptoms manifested in early infancy (3-6 months of age).
- Sporadic dystonic movements and mild mental retardation were observed.
Findings:
- Biochemical and genetic confirmation of tyrosine hydroxylase deficiency.
- All patients exhibited a rapid, favorable response to low-dose L-dopa/carbidopa.
- Motor performance improved significantly but remained incomplete.
Implications:
- TH deficiency is a treatable cause of early-onset parkinsonism.
- L-dopa/carbidopa offers a therapeutic option for managing symptoms.
- Further research into TH deficiency can elucidate catecholamine pathway roles in neurodevelopment.
Abstract:
Tyrosine hydroxylase deficiency was confirmed biochemically and genetically in four unrelated Dutch patients. The patients have a hypokinetic-rigid parkinsonian syndrome with symptoms in early infancy (3 to 6 months of age). Only sporadic dystonic movements were seen. There was no diurnal fluctuation. All patients showed a rapid favorable response to low-dose L-dopa/carbidopa treatment. Motor performance improved but did not fully normalize. The patients have mild mental retardation.